Author:
Rizk Elsie,Tajchman Sharla,Fink Ezekiel,Aryal Dipendra K.,Iso Tomona,Flores Eleazar,Brown Anthony E.,Chokshi Sagar P.,Desai Shetal-Nicholas,Dewan Ashvin K.,Kazzaz Sarah A.,Guevara Myriam,Nagaraj Sudha,Robben Christopher P.,Vittone Veronica,Swan Joshua T.
Abstract
Abstract
Background
Development of valid and feasible quality indicators (QIs) is needed to track quality initiatives for osteoarthritis pain management in primary care settings.
Methods
Literature search identified published guidelines that were reviewed for QI extraction. A panel of 14 experts was assembled, including primary care physicians, rheumatologists, orthopedic surgeons, pain specialists, and outcomes research pharmacists. A screening survey excluded QIs that cannot be reliably extracted from the electronic health record or that are irrelevant for osteoarthritis in primary care settings. A validity screening survey used a 9-point Likert scale to rate the validity of each QI based on predefined criteria. During expert panel discussions, stakeholders revised QI wording, added new QIs, and voted to include or exclude each QI. A priority survey used a 9-point Likert scale to prioritize the included QIs.
Results
Literature search identified 520 references published from January 2015 to March 2021 and 4 additional guidelines from professional/governmental websites. The study included 41 guidelines. Extraction of 741 recommendations yielded 115 candidate QIs. Feasibility screening excluded 28 QIs. Validity screening and expert panel discussion excluded 73 QIs and added 1 QI. The final set of 15 prioritized QIs focused on pain management safety, education, weight-management, psychological wellbeing, optimizing first-line medications, referral, and imaging.
Conclusion
This multi-disciplinary expert panel established consensus on QIs for osteoarthritis pain management in primary care settings by combining scientific evidence with expert opinion. The resulting list of 15 prioritized, valid, and feasible QIs can be used to track quality initiatives for osteoarthritis pain management.
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine,Rheumatology
Reference70 articles.
1. Centers for Disease Control and Prevention. Osteoarthritis (OA). 2020.
2. Centers for Disease Control and Prevention. A national public health agenda for osteoarthritis: 2020 update. 2020.
3. US Bone and Joint Initiative. The burden of musculoskeletal diseases in the United States. https://www.boneandjointburden.org/fourth-edition/iiib10/osteoarthritis. Accessed 27 June 2023.
4. Centers for Disease Control and Prevention. Joint Pain and Arthritis. 2020.
5. Alamanda VK, Wally MK, Seymour RB, Springer BD, Hsu JR, Prescription Reporting With Immediate Medication Utilization Mapping G. Prevalence of opioid and benzodiazepine prescriptions for osteoarthritis. Arthritis Care Res. 2020;72(8):1081–6.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献